A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

Cited by (1,001)

Items 301–400 of 1,001

1. The Impact of Bdnf Gene Deficiency to the Memory Impairment and Brain Pathology of APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease
   Tomi Rantamäki, Susanna Kemppainen, Henri Autio, Saara Stavén, Hennariikka Koivisto, Masami Kojima, Hanna Antila, Pasi O. Miettinen, Elisa Kärkkäinen, Nina N. Karpova et al. · 2013 · PLoS ONE
2. Chronic Exposure to Nerve Growth Factor Increases Acetylcholine and Glutamate Release from Cholinergic Neurons of the Rat Medial Septum and Diagonal Band of Broca via Mechanisms Mediated by p75 NTR
   Carey Y. L. Huh, Marc Danik, Frédéric Manseau, Louis‐Éric Trudeau, Sylvain Williams · 2008 · Journal of Neuroscience
3. NGF increases VEGF expression and promotes cell proliferation via ERK1/2 and AKT signaling in Müller cells.
   2016 · Europe PMC (PubMed Central)
4. Low-Intensity Pulsed Ultrasound Enhances Nerve Growth Factor-Induced Neurite Outgrowth through Mechanotransduction-Mediated ERK1/2–CREB–Trx-1 Signaling
   Lu Zhao, Yi Feng, Hong Hu, Aiwei Shi, Lei Zhang, Mingxi Wan · 2016 · Ultrasound in Medicine & Biology
5. Emerging vectors and targeting methods for nonviral gene therapy
   Matthieu D. Lavigne, Dariusz C. Górecki · 2006 · Expert Opinion on Emerging Drugs
6. The length of hippocampal cholinergic fibers is reduced in the aging brain
   Athéna Rebecca Ypsilanti, M. Teresa Girão da Cruz, Alison Burgess, Isabelle Aubert · 2007 · Neurobiology of Aging
7. β-Amyloid 1-42 Oligomers Impair Function of Human Embryonic Stem Cell-Derived Forebrain Cholinergic Neurons
   Linn Wicklund, Richardson Naves Leão, Anne‐Marie Strömberg, Malahat T. Mousavi, Outi Hovatta, Agneta K. Nordberg, Amelia Marutle · 2010 · PLoS ONE
8. Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons
   Valentina Latina, Silvia Caioli, Cristina Zona, Maria Teresa Ciotti, Giuseppina Amadoro, Pietro Calissano · 2017 · Frontiers in Cellular Neuroscience
9. Plasmid Biopharmaceuticals
   D.M.F. Prazeres, Gabriel Amaro Monteiro · 2014 · Microbiology Spectrum
10. Local Overexpression of Nerve Growth Factor in Rat Corneal Transplants Improves Allograft Survival
    Nianqiao Gong, Uwe Pleyer, Katrin Vogt, Ignacio Anegón, Alexander Flügel, Hans‐Dieter Volk, Thomas Ritter · 2007 · Investigative Ophthalmology & Visual Science
11. The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration
    Lilia Alberghina, Anna Maria Colangelo · 2006 · BMC Neuroscience
12. Nonpeptide neurotrophic agents useful in the treatment of neurodegenerative diseases such as Alzheimer's disease
    Masaaki Akagi, Nobuaki Matsui, Haruka Akae, Nana Hirashima, Nobuyuki Fukuishi, Yoshiyasu Fukuyama, Reiko Akagi · 2015 · Journal of Pharmacological Sciences
13. Stem cell transplantation for neurometabolic and neurodegenerative diseases
    Lamya S. Shihabuddin, Isabelle Aubert · 2009 · Neuropharmacology
14. In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model
    Yuanxin Chen, Victor V. Dyakin, Craig A. Branch, Babak Assai Ardekani, Dun‐Sheng Yang, David N. Guilfoyle, Jesse N. Peterson, Corrinne M. Peterhoff, Stephen D. Ginsberg, Anne M. Cataldo et al. · 2008 · Neurobiology of Aging
15. Transplantation of NGF-Gene-Modified Bone Marrow Stromal Cells into a Rat Model of Alzheimer’ Disease
    Liyan Li, Jintao Li, Qing-Ying Wu, Jin Li, Zhong-Tang Feng, Su Liu, Ting‐Hua Wang · 2007 · Journal of Molecular Neuroscience
16. Cell-Replacement and Gene-Therapy Strategies for Parkinson‘s and Alzheimer‘s Disease
    Joanna A. Korecka, Joost Verhaagen, Elly M. Hol · 2007 · Regenerative Medicine
17. The Expanding Universe of Neurotrophic Factors: Therapeutic Potential in Aging and Age-Associated Disorders
    Cristina Lanni, Serena Stanga, Marco Racchi, Stefano M. Govoni · 2010 · Current Pharmaceutical Design
18. Targeting reactive astrogliosis by novel biotechnological strategies
    Anna Maria Colangelo, Giovanni Cirillo, Marialuisa Lavitrano, Lilia Alberghina, Michèle Papa · 2011 · Biotechnology Advances
19. Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury
    Steffen Franz, Norbert Weidner, Armin Blesch · 2011 · Experimental Neurology
20. BB14, a Nerve Growth Factor (NGF)-like peptide shown to be effective in reducing reactive astrogliosis and restoring synaptic homeostasis in a rat model of peripheral nerve injury
    Giovanni Cirillo, Anna Maria Colangelo, Maria Rosaria Bianco, Carlo Cavaliere, Laura Zaccaro, Paolo Sarmientos, Lilia Alberghina, Michèle Papa · 2011 · Biotechnology Advances
21. Alleviation of Aβ-induced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model
    D Takeuchi, Naoyuki Sato, Munehisa Shimamura, Hitomi Kurinami, Shunichi Takeda, M Shinohara, Shingo Suzuki, Masami Kojima, Toshio Ogihara, Ryuichi Morishita · 2008 · Gene Therapy
22. Mouse models in neurological disorders: Applications of non-invasive imaging
    Yannic Waerzeggers, Parisa Monfared, Thomas Viel, Alexandra Winkeler, Andreas Hans Jacobs · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
23. Current therapeutic strategy in Alzheimer's disease.
    S Singh, Ajay Singh Kushwah, R Singh, M Farswan, R Kaur · 2012 · PubMed
24. Opportunities and challenges in developing Alzheimer disease therapeutics
    Khalid Iqbal, Inge Grundke · 2011 · Acta Neuropathologica
25. Recombinant human NGF-loaded microspheres promote survival of basal forebrain cholinergic neurons and improve memory impairments of spatial learning in the rat model of Alzheimer's disease with fimbria-fornix lesion
    Haigang Gu, Dahong Long, Cunxian X. Song, Xiaobin Li · 2009 · Neuroscience Letters
26. BMP9 (Bone Morphogenetic Protein 9) Induces NGF as an Autocrine/Paracrine Cholinergic Trophic Factor in Developing Basal Forebrain Neurons
    Aletta C. Schnitzler, Tiffany J. Mellott, Ignacio López-Coviella, Yvonne N. Tallini, Michael I. Kotlikoff, Maximillian T. Follettie, Jan Krzysztof Blusztajn · 2010 · Journal of Neuroscience
27. Phenylbutenoid dimers isolated from Zingiber purpureum exert neurotrophic effects on cultured neurons and enhance hippocampal neurogenesis in olfactory bulbectomized mice
    Nobuaki Matsui, Yuki Kido, Hideki Okada, Miwa Kubo, Megumi Nakai, Nobuyuki Fukuishi, Yoshiyasu Fukuyama, Masaaki Akagi · 2012 · Neuroscience Letters
28. Prolonged controlled delivery of nerve growth factor using porous silicon nanostructures
    Neta Zilony, Michal Rosenberg, Liran Holtzman, Hadas Schori, Orit Shefi, Ester Segal · 2016 · Journal of Controlled Release
29. Production of nerve growth factor by β‐amyloid‐stimulated astrocytes induces p75NTR‐dependent tau hyperphosphorylation in cultured hippocampal neurons
    Estefanía T. Sáez, Mariana Pehar, Marcelo R. Vargas, Luis Barbeito, Ricardo Benjamin Maccioni · 2006 · Journal of Neuroscience Research
30. Alzheimers Disease - An Interactive Perspective
    Klaus Heese, Hiroyasu Akatsu · 2006 · Current Alzheimer Research
31. Galanin – 25 years with a multitalented neuropeptide
    Scott Counts, Sylvia E. Perez, Elliott Jay Mufson · 2008 · Cellular and Molecular Life Sciences
32. The development of encapsulated cell technologies as therapies for neurological and sensory diseases
    Mark Zanin, Lisa N. Pettingill, A.R. Harvey, Df Emerich, Chris G. Thanos, Robert K. Shepherd · 2012 · Journal of Controlled Release
33. Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function
    Csilla Ari, Sergiy I. Borysov, Jiashin Wu, Jaya Padmanabhan, Huntington Potter · 2014 · Neurobiology of Aging
34. Small molecule activators of the Trk receptors for neuroprotection
    Nicholas J. G. Webster, Michael C. Pirrung · 2008 · BMC Neuroscience
35. Ligand-Dependent TrkA Activity in Brain Differentially Affects Spatial Learning and Long-Term Memory
    Tahar Aboulkassim, Xin‐Kang Tong, Yiu Chung Tse, Tak Pan Wong, Sang Bum Woo, Kenneth Neet, Fouad Brahimi, Édith Hamel, Horacio Uri Saragovi · 2011 · Molecular Pharmacology
36. Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies
    Xhima, Kristiana, Markham-Coultes, Kelly, Hahn Kofoed, Rikke, Saragovi, H Uri, Hynynen, Kullervo, Aubert, Isabelle · 2022 · Brain
37. Role of nerve growth factor in plasticity of forebrain cholinergic neurons
    Н. К. Исаев, Elena V. Stelmashook, Е. Е. Генрихс · 2017 · Biochemistry (Moscow)
38. The promise of human embryonic stem cells in aging-associated diseases
    Odessa Yabut, Harold S. Bernstein · 2011 · Aging
39. Stem cell therapeutics and gene therapy for neurologic disorders
    Kevin S. Chen, Emily J. Koubek, Stacey A. Sakowski, Eva L. Feldman · 2024 · Neurotherapeutics
40. A selective role for ARMS/Kidins220 scaffold protein in spatial memory and trophic support of entorhinal and frontal cortical neurons
    Áine Duffy, Michael J. Schaner, Synphen H. Wu, Agnieszka Staniszewski, Asok R. Kumar, Juan Carlos Arévalo, Ottavio Arancio, Moses V. Chao, Helen E. Scharfman · 2011 · Experimental Neurology
41. Selective and differential interactions of BNN27, a novel C17-spiroepoxy steroid derivative, with TrkA receptors, regulating neuronal survival and differentiation
    Iosif Pediaditakis, Paschalis Efstathopoulos, Kyriakos C. Prousis, María Zervoú, Juan Carlos Arévalo, Vasileia Ismini Alexaki, Vassiliki Nikoletopoulou, Efthymia Karagianni, Constantinos Potamitis, Nektarios Tavernarakis et al. · 2016 · Neuropharmacology
42. Gene therapy and transplantation in the retinofugal pathway
    Alan R. Harvey, Mats Hellström, Jennifer Rodger · 2009 · Progress in brain research
43. The Role of Neurotrophins in Multiple Sclerosis—Pathological and Clinical Implications
    Alicja Kalinowska, Jacek Losy · 2012 · International Journal of Molecular Sciences
44. Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease
    Edward M. Rockenstein, Paula Desplats, Kiren K. Ubhi, Michael Mante, Jazmin B. Florio, Anthony Adame, Stefan Winter, Hemma Brandstaetter, Dieter Meier, Eliezer Masliah · 2015 · Stem Cell Research
45. Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
    Jana Miniarikova, Melvin M. Evers, Pavlina S. Konstantinova · 2018 · Molecular Therapy
46. Nasal delivery of nerve growth factor rescue hypogonadism by up-regulating GnRH and testosterone in aging male mice
    Luo, Jiao, Yang, Yan, Zhang, Tiantian, Su, Zhijian, Yu, Dan, Lin, Qilian, Chen, Haolin, Zhang, Qihao, Xiang, Qi, Xue, Wei et al. · 2018 · EBioMedicine
47. Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells
    Antonino Cattaneo, Simona Capsoni · 2018 · Pharmacological Research
48. Neurotrophic Factors in Neurodegenerative Disorders
    Fabio Fumagalli, Raffaella Molteni, Francesca Calabrese, Paola Francesca Maj, Giorgio Racagni, Marco Andrea Riva · 2008 · CNS Drugs
49. p53 Pro-Oxidant Activity in the Central Nervous System: Implication in Aging and Neurodegenerative Diseases
    Wassim Chatoo, Mohamed Abdouh, Gilbert Bernier · 2010 · Antioxidants and Redox Signaling
50. Long-Term Gene Therapy Causes Transgene-Specific Changes in the Morphology of Regenerating Retinal Ganglion Cells
    Jennifer Rodger, Eleanor Drummond, Mats Hellström, Donald Robertson, Alan R. Harvey · 2012 · PLoS ONE
51. Adeno‐associated virus‐mediated gene delivery approaches for the treatment of CNS disorders
    Dimitra Terzi, Venetia Zachariou · 2008 · Biotechnology Journal
52. Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion
    Castle, Michael J., Cheng, Yuhsiang, Asokan, Aravind, Tuszynski, Mark H. · 2018 · Science Advances
53. Progress in the development of new drugs in Alzheimer's disease
    Piau, Antoine, Nourhashémi, F., Hein, C., Caillaud, C., Vellas, B. · 2011 · The Journal of nutrition, health and aging
54. Pharmaceutical treatment for cognitive deficits in Alzheimer’s disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps
    Raymond T. Bartus, Reginald L. Dean · 2008 · Psychopharmacology
55. Nicotine‐induced enhancement of synaptic plasticity at CA3–CA1 synapses requires GABAergic interneurons in adult anti‐NGF mice
    Marcelo D. Rosato‐Siri, Antonino Cattaneo, Enrico Cherubini · 2006 · The Journal of Physiology
56. Beneficial Effect of a CNTF Tetrapeptide on Adult Hippocampal Neurogenesis, Neuronal Plasticity, and Spatial Memory in Mice
    Julie Blanchard, Muhammad Omar Chohan, Bin Li, Fei Liu, Khalid Iqbal, Inge Grundke · 2010 · Journal of Alzheimer s Disease
57. Curiosity and cure: Translational research strategies for neural repair‐mediated rehabilitation
    Bruce H. Dobkin · 2007 · Developmental Neurobiology
58. Intranasal administration of TAT-haFGF14–154 attenuates disease progression in a mouse model of Alzheimer’s disease
    Guofeng Lou, QI-HAO ZHANG, Fei Xiao, Qi Xiang, Zishan Su, L. Zhang, Penghui Yang, Yan Fang Yang, Qiusheng Zheng, Yishan Huang · 2012 · Neuroscience
59. Neurobiology of pain, interoception and emotional response: lessons from nerve growth factor‐dependent neurons
    Yasuhiro Indo · 2014 · European Journal of Neuroscience
60. The Beneficial Role of Vitamin D in Alzheimer’s Disease
    Khanh vinh quốc Lương, Lan Nguyễn · 2011 · American Journal of Alzheimer s Disease & Other Dementias®
61. Possibility of a New Anti-Alzheimerʼs Disease Pharmaceutical Composition Combining Memantine and Vitamin D
    Cédric Annweiler, Olivier Beauchet · 2012 · Drugs & Aging
62. The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
    Francesca Cicchetti, Roger A. Barker · 2014 · Frontiers in Pharmacology
63. Co-encapsulation ofNigella sativaoil and plasmid DNA for enhanced gene therapy of Alzheimer’s disease
    Abd Almonem Doolaanea, Nur Izzati Mansor, Nurul Hafizah Mohd Nor, Farahidah Mohamed · 2016 · Journal of Microencapsulation
64. Recent Advances in Mono- and Combined Stem Cell Therapies of Stroke in Animal Models and Humans
    Roxana Surugiu, Andrei Olaru, Dirk Matthias Hermann, Daniela Glăvan, Bogdan Cătălin, Aurel Popa‐Wagner · 2019 · International Journal of Molecular Sciences
65. Therapeutic potential of neurotrophic factors in Alzheimer’s Disease
    Ava Nasrolahi, Fatemeh Javaherforooshzadeh, Mohsen Jafarzadehgharehziaaddin, Javad Mahmoudi, Khadijeh Dizaji Asl, Zahra Shabani · 2021 · Molecular Biology Reports
66. New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism
    Carlye A. Szarowicz, Kathy Steece‐Collier, Margaret E. Caulfield · 2022 · International Journal of Molecular Sciences
67. From Lab Bench to Hope: Emerging Gene Therapies in Clinical Trials for Alzheimer’s Disease
    Angelica Ortega, Brendan P Chernicki, Grace Ou, Mayur S. Parmar · 2024 · Molecular Neurobiology
68. Deliberative assessment of surrogate consent in dementia research
    Scott Y. H. Kim, Rebecca A. Uhlmann, Paul S. Appelbaum, David S. Knopman, Hyungjin Myra Kim, Laura J. Damschroder, Elizabeth Beattie, Laura M. Struble, Raymond G. De Vries · 2010 · Alzheimer s & Dementia
69. Pharmaceutical implants: classification, limitations and therapeutic applications
    Zahra Mohtashami, Zahra Esmaili, Molood Alsadat Vakilinezhad, Ehsan Seyedjafari, Hamid Akbari Javar · 2019 · Pharmaceutical Development and Technology
70. Novel approaches for immunotherapeutic intervention in Alzheimer's disease
    Vitaly Vasilevko, David H. Cribbs · 2006 · Neurochemistry International
71. The potential of biomaterials for central nervous system cellular repair
    Sarah Jarrin, Sílvia Cabré, Eilís Dowd · 2021 · Neurochemistry International
72. Nerve Growth Factor-Based Therapy in Alzheimer’s Disease and Age-Related Macular Degeneration
    Giuseppina Amadoro, Valentina Latina, Bijorn Omar Balzamino, Rosanna Squitti, Monica Varano, Pietro Calissano, Alessandra Micera · 2021 · Frontiers in Neuroscience
73. The capacity to appoint a proxy and the possibility of concurrent proxy directives
    Scott Y. H. Kim, Paul S. Appelbaum · 2006 · Behavioral Sciences & the Law
74. The Inorganic Side of NGF: Copper(II) and Zinc(II) Affect the NGF Mimicking Signaling of the N-Terminus Peptides Encompassing the Recognition Domain of TrkA Receptor
    Giuseppe Pandini, Cristina Satriano, Adriana Pietropaolo, Fiorenza Gianì, Alessio Travaglia, Diego La Mendola, Vincenzo Giuseppe Nicoletti, Enrico Rizzarelli · 2016 · Frontiers in Neuroscience
75. Novel Therapeutic Strategies in Alzheimer’s Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond
    Giacomo Tondo, Fabiola De Marchi, Francesca Bonardi, Federico Menegon, Gaia Verrini, Davide Aprile, Matteo Anselmi, Letizia Mazzini, Cristoforo Comi · 2024 · Journal of Clinical Medicine
76. Cell and Gene Therapy in Alzheimer's Disease
    Micaela Johanna Glat, Daniel Offen · 2013 · Stem Cells and Development
77. Nerve growth factor gene delivery: Animal models to clinical trials
    Mark H. Tuszynski · 2007 · Developmental Neurobiology
78. Neurogenesis as a potential therapeutic strategy for neurodegenerative diseases
    Kurt A. Sailor, Guo‐li Ming, Hongjun Song · 2006 · Expert Opinion on Biological Therapy
79. sAPP Enhances the Transdifferentiation of Adult Bone Marrow Progenitor Cells to Neuronal Phenotypes
    Chun-Wei David Chen, Rene Maurice Boiteau, Wen‐Fu Lai, Steven W. Barger, Anne M. Cataldo · 2006 · Current Alzheimer Research
80. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease
    Scott Counts, Shaoli Che, Stephen D. Ginsberg, Elliott Jay Mufson · 2011 · Journal of Chemical Neuroanatomy
81. Neuroprotective therapies for multiple sclerosis and other demyelinating diseases
    Pablo Villoslada · 2016 · Multiple Sclerosis and Demyelinating Disorders
82. First Look at the Venom of Naja ashei
    Konrad K. Hus, Justyna Buczkowicz, Vladimír Petrilla, Monika Petrillová, Andrzej Łyskowski, Jaroslav Legáth, Aleksandra Bocian · 2018 · Molecules
83. Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences
    Timothy M. Baran, Feng Vankee Lin, Alzheimer’s Disease Neuroimaging Initiative · 2018 · Journal of Alzheimer s Disease
84. Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafness
    Patricia A. Leake, Omar Akil, Hainan Lang · 2020 · Hearing Research
85. Phenolic molecules constructed nanomedicine for innovative cancer treatment
    Quguang Li, Ziliang Dong, Meiwan Chen, Liangzhu Feng · 2021 · Coordination Chemistry Reviews
86. Acupuncture and Neurotrophin Modulation
    Marzia Soligo, Stefania Lucia Nori, Virginia Protto, Fulvio Florenzano, Luigi Manni · 2013 · International review of neurobiology
87. Efficient Gene Delivery to Mesenchymal Stem Cells by an Ethylenediamine‐Modified Polysaccharide from Mulberry Leaves
    Wenwen Deng, Xia Cao, Miao Wang, Yan Fang Yang, Wei‐Yan Su, Ya‐Wei Wei, Zhen Ouyang, Jiangnan Yu, Ximing Xu · 2011 · Small
88. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors
    G. Scott Ralph, Katie Binley, Liang‐Fong Wong, Mimoun Azzouz, Nicholas D. Mazarakis · 2005 · Clinical Science
89. The role of positron emission tomography imaging in understanding Alzheimer’s disease
    Henryk Barthel, John Peter Seibyl, Osama Sabri · 2015 · Expert Review of Neurotherapeutics
90. Neuroprotective Effect of Nerve Growth Factor Loaded in Porous Silicon Nanostructures in an Alzheimer's Disease Model and Potential Delivery to the Brain
    Neta Zilony, Michal Rosenberg, Michal Richman, Ronen Yehuda, Hadas Schori, Menachem Motiei, Shai Rahimipour, Alexander Groisman, Ester Segal, Orit Shefi · 2019 · Small
91. The search for, and chemistry and mechanism of, neurotrophic natural products
    Yoshiyasu Fukuyama, Miwa Kubo, Kenichi Harada · 2020 · Journal of Natural Medicines
92. Enhancing peripheral nerve regeneration with neurotrophic factors and bioengineered scaffolds: A basic science and clinical perspective
    Brian V. Lien, Nolan James Brown, Seth C. Ransom, Brandon M. Lehrich, Shane Shahrestani, Ali R. Tafreshi, Ryan C. Ransom, Ronald Sahyouni · 2020 · Journal of the Peripheral Nervous System
93. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury
    Jennie E. Minnich, Sarah L. Mann, Megan Stock, Kathryn A. Stolzenbach, Bridget M. Mortell, Katherine E. Soderstrom, Martha Churchill Bohn, Dorothy Annette Kozlowski · 2010 · Restorative Neurology and Neuroscience
94. Does the term ‘trophic’ actually mean anti-amyloidogenic? The case of NGF
    Pietro Calissano, Giuseppina Amadoro, Carmela Matrone, Stefania Ciafrè, Roberta Marolda, Veronica Corsetti, Maria Teresa Ciotti, Delio Mercanti, Anna Di Luzio, Cinzia Severini et al. · 2010 · Cell Death and Differentiation
95. RETRACTED ARTICLE: Exploring the Therapeutic Effect of Neurotrophins and Neuropeptides in Neurodegenerative Diseases: at a Glance
    Md. Mominur Rahman, Md. Rezaul Islam, Fatema Akter Supti, Puja Sutro Dhar, Sheikh Shohag, Jannatul Ferdous, Shakil khan shuvo, Aklima Akter, Md. Sarowar Hossain, Rohit Sharma · 2023 · Molecular Neurobiology · Retracted
96. Beta Amyloid Suppresses the Expression of the Vitamin D Receptor Gene and Induces the Expression of the Vitamin D Catabolic Enzyme Gene in Hippocampal Neurons
    Erdinç Dursun, Duygu Gezen‐Ak, Selma Yılmazer · 2013 · Dementia and Geriatric Cognitive Disorders
97. Cerebellin 4, a synaptic protein, enhances inhibitory activity and resistance of neurons to amyloid-β toxicity
    Pedro J. Chacón, Àngel del Marco, María‐Ángeles Arévalo, Paloma Domínguez-Giménez, Luis Miguel García‐Segura, Alfredo Rodrı́guez-Tébar · 2014 · Neurobiology of Aging
98. Effect of public deliberation on attitudes toward surrogate consent for dementia research
    Scott Y. H. Kim, H.M. Kim, David S. Knopman, Raymond G. De Vries, Laura J. Damschroder, Paul S. Appelbaum · 2011 · Neurology
99. Public's Approach to Surrogate Consent for Dementia Research: Cautious Pragmatism
    Raymond G. De Vries, Kerry A. Ryan, Aimee Stanczyk, Paul S. Appelbaum, Laura J. Damschroder, David S. Knopman, Scott Y. H. Kim · 2013 · American Journal of Geriatric Psychiatry
100. REMOVED: Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in Alzheimer's disease
     Hari Shanker Sharma, Dafin Fior Muresanu, Ala Nozari, José Vicente Lafuente, Z. Ryan Tian, Asya Ozkızılcık, Igor Manzhulo, Herbert Mössler, Aruna Sharma · 2019 · Progress in brain research